透過您的圖書館登入
IP:3.21.34.0
  • 學位論文

專利權證券化之可行性分析

Feasibility Analysis of Patent Backed Securitization

指導教授 : 廖咸興
共同指導教授 : 林煜宗
若您是本文的作者,可授權文章由華藝線上圖書館中協助推廣。

摘要


資產證券化(Asset Securitization)是自1970年代以來的一種新興融資方式,其特點在於以特定資產之預期未來現金流量,做為日後償還本息的基礎(或擔保),來發行證券,而非傳統授信時著眼於借款人之整體獲利能力。專利權證券化即是以專利權未來所產生的現金流量(專利授權權利金)為擔保基礎,發行證券向投資人募資,以提前獲得一筆資金的過程。2000年耶魯大學(Yale University)將一種可抑制HIV病毒繁衍的愛滋藥物「滋利特(Zerit)」未來權利金收益證券化,為第一宗專利權證券化的案例,開啟了資產證券化市場的新頁。 本篇論文首先整理出實務界常用的數種專利鑑價方法和專利授權權利金的影響因素,接著提出三種專利權證券化的基本概念,分別是專利權擔保貸款債權證券化、含有授權契約之專利權證券化與尚無授權契約之專利權證券化,進而分析專利權證券化所面臨的風險,針對不同產業之生命週期特性給予建議,並提供兩種可能之信用增強方式以供參考,最後也將介紹耶魯大學之專利權證券化個案。 鑑於國內已於民國91年6月通過金融資產證券化條例,相關產品已陸續於市場上推出,證券化技巧可望逐漸成熟,倘若未來能搭配更完善的法律規範和配套機制,例如建立專利鑑價機制、建置專利交易平台以及設立信用保證基金等,相信有朝一日應可提供專利權發明者一種利用專利權的新融資工具,增加其取得資金的管道,最終達到提高產業競爭力之目的。

並列摘要


Asset securitization has been a new financing method since the 1970s. The characteristic that differentiates asset securitization from traditional types of financing is that the future repayment of principal and interest comes from expected cash flow generated from specific assets, instead of depending on the borrower’s overall profitability. Patent backed securitization is the process of acquiring funds ahead of time in the means of issuing securities to investors. The collateral for the securities themselves involved the right to future cash flow from the patents, i.e. patent licensing royalties. Yale University securitized its future patent royalty stream on a anti-HIV drug Zerit in year 2000, which is the first case of patent backed securitization. It promises a new era in the asset securitization market. This thesis first reviews several patent valuation techniques frequently used in practice and factors that influence patent royalties as well. Next three basic concepts of packaging patents as asset backed securities are introduced, which is securitization of patent backed loans, securitization of patents with existing licensing agreements and securitization of non-licensed patent rights. The author then analyzes the risk and gives advice in accordance with different product life cycle patterns of industries. Furthermore two potential ways of credit enhancement are mentioned. The case of Yale is also included ultimately. Because of approval of the Financial Asset Securitization Law in June 2002, some transactions were already been launched since then. It is hoped that the securitization techniques and skills will make progress gradually. Patent backed securitization is a new funding tool for inventors to unlock their patent value, provided that there is more matching legislation and mechanism. For example, patent valuation systems, patent exchange markets and credit guarantee funds. As a result, patent inventors can acquire a new mean of financing. Eventually the goal of enhancing industry competitiveness is reached.

參考文獻


23.金融資產證券化條例,民國91年7月24日發布。
4.林衛理、鄭惠蓉,「生技智財權為銀行附認股選擇權放款業務擔保品之研究」,臺灣經濟研究月刊第26卷第1期,2003年1月。
21.嚴文巧,「產品生命週期之決策模式研究」,國立成奶j學工業管理研究所碩士論文,2003年6月。
3.Bristol-Myers Squibb Company, “2003 Annual Report”
4.Bruce Berman (editor), “From Ideas to Assets: Investing Wisely in Intellectual Property.” John Wiley & Sons, Inc. 2002

被引用紀錄


林千惠(2006)。生技製藥產業無形資產評價分析—實質選擇權法〔碩士論文,淡江大學〕。華藝線上圖書館。https://doi.org/10.6846/TKU.2006.01195
Chen, S. Y. J. (2007). 專利管理與鑑價之探討 [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2007.01897
劉茹萍(2006)。應收帳款債權證券化之台灣個案實證研究〔碩士論文,國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2006.00048

延伸閱讀